ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Ensysce Biosciences Announces Closing of Merger firstwordpharma
July 01, 2021Ensysce Biosciences, Inc. ("Ensysce" or the "Company") (NASDAQ: ENSC) (OTC: ENSCW) today announced that it has closed its previously announced merger with Leisure Acquisition Corp. ("LACQ"). -
“At Home Coronavirus Pill” to Advance to Phase 2 Clinical Development americanpharmaceuticalreview
May 08, 2021Ensysce Biosciences, Inc. announced that Ensysce’s subsidiary, Covistat, will be presenting at the upcoming American Thoracic Society (ATS) Annual Meeting to be held May 14-19, 2021. -
Recro, Ensysce Expand Development and Manufacturing Partnership contractpharma
April 16, 2021?Recro Pharma, a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges for companies developing oral solid dose drug products, has signed additional agreements with an existing ...
Pharma Sources Insight January 2025
